DHL is a B-cell lymphoma that carries rearrangements between MYC and another oncogene, usually BCL2 and more rarely BCL6, BCL3, or CCND1. DHL and triple-hit lymphoma represent about 10% of all DLBCL [44]. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.